Molecular Templates, Inc.

  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
  • Technology
    • Overview
    • Posters
    • Articles
  • Pipeline
    • Overview
    • MT-6402
    • MT-5111
    • MT-0169
  • Clinical Trials
    • Overview
    • Expanded Access
  • News & Media
    • Press Releases
    • Presentations
    • Events
  • Investors
    • Overview
    • Presentations
    • Company Info
    • Financial Info
    • Stock Data
    • SEC Filings
    • Governance
    • Email Alerts
  • Contact
  • Careers

Press Releases

News & Media

News & Media

  • Press Releases
  • Presentations
  • Events

Molecular Templates, Inc. Announces Proposed Public Equity Offering

Nov 20, 2019 4:01pm EST

Vertex and Molecular Templates Establish Collaboration to Discover and Develop Novel Targeted Conditioning Regimens to Enhance Hematopoietic Stem Cell Transplants

Nov 18, 2019 7:00am EST

Molecular Templates, Inc. Reports Third Quarter 2019 Financial Results

Nov 12, 2019 5:00pm EST

Molecular Templates Hosting Analyst & Investor Meeting

Nov 07, 2019 4:27pm EST

Molecular Templates to Present at the Ladenburg ThalmannĀ and Cantor Fitzgerald Healthcare Conferences

Sep 23, 2019 4:30pm EDT

Molecular Templates, Inc. Reports Second Quarter 2019 Financial Results

Aug 12, 2019 4:30pm EDT

Molecular Templates Announces FDA Acceptance of IND Application for TAK-169, An Engineered Toxin Body Targeting CD38

Jun 17, 2019 8:00am EDT

Molecular Templates to Present at the Oppenheimer New York Oncology Insight Summit and the UBS Global Healthcare Conference

May 14, 2019 4:30pm EDT

Molecular Templates, Inc. Reports First Quarter 2019 Financial Results

May 13, 2019 4:01pm EDT

Molecular Templates Announces FDA Acceptance of IND Application for MT-5111, An Engineered Toxin Body Targeting HER2

Apr 22, 2019 8:00am EDT
RSS
  • Prev
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
    • 10
    • ...12
    Next
    © 2023 Molecular Templates, Inc. All Rights Reserved.
    Twitter Linkedin
    Privacy Policy Disclaimer Terms of Use Sitemap Expanded Access